Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study

Wang, Chung-JingChung-JingWangLin, Yu-NanYu-NanLinSHI-WEI HUANGChang, Chien-HsingChien-HsingChang2024-02-232024-02-232011-0100225347https://scholars.lib.ntu.edu.tw/handle/123456789/639901We evaluated the long-term efficacy and safety of low dose oral desmopressin in elderly patients with benign prostatic hyperplasia with more than nocturnal voids and nocturnal polyuria more than 30% of total daily urine volume.enDeamino arginine vasopressin | Nocturia | Polyuria | Prostatic hyperplasiaLow dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized studyjournal article10.1016/j.juro.2010.08.095210747902-s2.0-78650025699https://api.elsevier.com/content/abstract/scopus_id/78650025699